65.50
Halozyme Therapeutics Inc (HALO) 最新ニュース
Torray Investment Partners LLC Has $2.08 Million Stock Holdings in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Arkadios Wealth Advisors Acquires 11,457 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Will Halozyme Therapeutics Inc. price bounce be sustainableJuly 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - newser.com
Will Halozyme Therapeutics Inc. stock benefit from upcoming earnings reportsQuarterly Portfolio Review & AI Driven Price Predictions - newser.com
Can Halozyme Therapeutics Inc. stock continue upward trendTrade Volume Summary & Low Volatility Stock Suggestions - newser.com
Using Python tools to backtest Halozyme Therapeutics Inc. strategiesWeekly Trend Recap & Technical Pattern Based Signals - newser.com
Halozyme Therapeutics (HALO) Anticipates Strong Q3 Earnings Grow - GuruFocus
Will Halozyme Therapeutics Inc. stock see PE expansionMarket Activity Report & High Accuracy Investment Signals - newser.com
Why Halozyme Therapeutics Inc. stock could be next big winnerShort Setup & Real-Time Volume Triggers - newser.com
Retirement Systems of Alabama Sells 4,246 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Combining price and volume data for Halozyme Therapeutics Inc.Layoff News & Expert Approved Momentum Trade Ideas - newser.com
AlphaQuest LLC Purchases 5,133 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Will Halozyme Therapeutics Inc. stock benefit from infrastructure spendingCPI Data & Proven Capital Preservation Methods - newser.com
HALOZYME THERAPEUTICS Earnings Preview: Recent $HALO Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
What insider trading reveals about Halozyme Therapeutics Inc. stockJuly 2025 PostEarnings & Reliable Momentum Entry Alerts - newser.com
Halozyme Therapeutics, Inc. $HALO Stock Position Lowered by Hantz Financial Services Inc. - MarketBeat
Tools to assess Halozyme Therapeutics Inc.’s risk profilePortfolio Return Summary & Accurate Entry/Exit Alerts - newser.com
Backtesting results for Halozyme Therapeutics Inc. trading strategies2025 Fundamental Recap & AI Driven Stock Reports - newser.com
Will Halozyme Therapeutics Inc. (RV7) stock outperform global peersWeekly Trend Recap & AI Powered Trade Plan Recommendations - newser.com
argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients - GlobeNewswire Inc.
Halozyme Therapeutics, Inc. $HALO Shares Acquired by Mizuho Markets Americas LLC - MarketBeat
94,601 Shares in Halozyme Therapeutics, Inc. $HALO Bought by Y Intercept Hong Kong Ltd - MarketBeat
大文字化:
|
ボリューム (24 時間):